
Adam Luginbuhl MD
Head & Neck Microvascular Surgery, Head & Neck Oncologic Surgery
Assistant Professor, Otolaryngology, Thomas Jefferson University
Join to View Full Profile
925 Chestnut StFl 6Philadelphia, PA 19107
Phone+1 215-955-6760
Fax+1 215-923-4532
Dr. Luginbuhl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Head & Neck Surgical Oncology/Microvascular Reconstruction, 2012 - 2013
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Otolaryngology - Head and Neck Surgery, 2007 - 2012
Uconn School Of MedicineClass of 2007
University of PennsylvaniaB.S., 2002
Certifications & Licensure
DE State Medical License 2021 - 2027
NJ State Medical License 2013 - 2027
PA State Medical License 2007 - 2026
TN State Medical License 2012 - 2013
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2014-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2014-2017
Clinical Trials
- Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer Start of enrollment: 2014 Jul 22
- Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer Start of enrollment: 2017 Jan 05
- Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck Start of enrollment: 2019 Apr 09
Publications & Presentations
PubMed
- Saliva vs Plasma in Liquid Biopsy Sampling for Head and Neck Cancer: A Comparative Study.Mouadh Barbirou, Amanda Miller, David Baek, Allison Hameier, Ashley Wetzel
Clinical Chemistry. 2026-04-28 - Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Survival Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Neoadjuvant Immunotherapy.Pablo Llerena, Praneet C Kaki, Kathryn Nunes, Eric Mastrolonardo, Kelly Bridgham
Cancer Medicine. 2026-03-01 - 1 citationsAccuracy of frozen section for HPV-Associated squamous cell carcinoma of unknown primary.Sindhura Sridhar, Annie Moroco, Shravan Gowrishankar, Mitra Mehrad, Kim Ely
Oral Oncology. 2026-03-01
Journal Articles
- Association of Positive Initial Margins with Survival Among Patients with Squamous Cell Carcinoma Treated with Total LaryngectomyCorey Savard, David Cognetti, Michael C Topf, William Keane, Joseph Curry, Patrick Tassone, Adam Luginbuhl, JAMA
- Prospective Randomized Controlled Trial Using Best-Selling Smoking Cessation BookFoshbee J, Oh Anita, Curry J, Keane, W, Cognetti, D, ENT Journal, 1/1/2015
- Current management of locally advanced head and neck cancer: the combination of chemotherapy with locoregional treatmentsBar-Ad V, Palmer J, Yang H, Cognetti D, Curry J, Tuluc M, Campling B, Axelrod R, Seminars in Oncology Journal, 1/1/2014
Abstracts/Posters
- Cervical Spine Osteomyelitis after Esophageal Dilation in Patients with a History of Laryngectomy or Pharyngectomy and Pharyngeal IrradiationSouza J, Goldman R, Curry J, Heller J, Cognetti D, American Head Neck Society 5thAnnual Meeting, New York, NY, 1/1/2014
- Management of the External Auditory Canal in Free Flap Reconstruction of Total Auriculectomy DefectsArtz G, Cognetti D, Curry J, Heffelfinger R, Krein H, American Head Neck Society 5thAnnual Meeting, New York, NY, 1/1/2014
- Transoral Robotic Surgery for Parapharyngeal Space TumorsNguyen A, Cognetti D, Triologic Society Meeting, Phoenix, AZ, 1/1/2011
Lectures
- Discordant treatment response in primary tumors and lymph node metastases after four weeks of preoperative PD-1 blockade in head and neck squamous cell carcinoma (HNSCC).2019 ASCO Annual Meeting - 6/1/2019
- Novel therapeutic approach using triterpenoid RTA to prevent radiation-associated tissue injury and fibrosis in rodent modelBoston, MA - 1/1/2015
- Updates on Oropharyngeal CancerJennersville Hospital, Jennersville, PA - 1/1/2014
Press Mentions
Sleep Apnea, Hearing Loss, Cancer, Airway Disorders, Facial Nerve Conditions, and More Presented at AAO-HNSF 2025 Annual MeetingOctober 13th, 2025
2025 Best of Scientific Orals Showcase Cutting-Edge ResearchSeptember 29th, 2025
Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant NivolumabJuly 31st, 2025
External Links
- Adam Luginbuhlhttp://www.jeffersonhospital.org/find-a-doctor/l/luginbuhl-adam-j/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









